Literature DB >> 15946136

Gender differences in vascular reactivity of aortas from rats with and without portal hypertension.

René Robert1, Carine Chagneau-Derrode, Michel Carretier, Gérard Mauco, Christine Silvain.   

Abstract

BACKGROUND: Inflammatory responses related to portal hypertension may be different in male and female rats. Most experimental studies of portal hypertension have involved male animals, and little information is available on gender differences in this setting. The aim of the present study was to compare aortic reactivity in female and male rats with and without portal hypertension.
METHODS: Contraction response curves to phenylephrine were studied with aortic rings, with and without endothelium. For relaxation studies, rings were precontracted with phenylephrine 10(-7) mol/L and then exposed to acetylcholine 10(-4) mol/L. Portal hypertension was provoked by calibrated portal stenosis performed 2 weeks before experiments.
RESULTS: In non-hypertensive conditions, the contractile response to increasing phenylephrine concentrations was significantly stronger in rings from male than female rats, both with and without endothelium. In male rats with portal hypertension, the phenylephrine concentration-response curves were lowered and shifted to the right in aortic rings both with and without endothelium. In female rats, portal hypertension did not induce significant changes in the phenylephrine concentration-response curves. In female rats, portal hypertension induced a marked increase in relaxation (157 +/- 123% vs 81 +/- 64% in controls); the increase was also stronger than that in male rats with portal hypertension (95 +/- 6%; P < 0.01).
CONCLUSION: Clear gender differences were observed in vasoconstrictor responsiveness of aortic rings from rats with and without portal hypertension. Contrary that in male rats, portal hypertension did not induce vascular hyporesponsiveness in female rats. Further investigations are required to explain these differences. (c) 2005 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946136     DOI: 10.1111/j.1440-1746.2005.03805.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Sexual dimorphism in rat aortic endothelial function of streptozotocin-induced diabetes: possible involvement of superoxide and nitric oxide production.

Authors:  Xiaoyuan Han; Rui Zhang; Leigh Anderson; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2013-11-06       Impact factor: 4.432

2.  Sex-specific differences in chromosome-dependent regulation of vascular reactivity in female consomic rat strains from a SSxBN cross.

Authors:  Mary Pat Kunert; Melinda R Dwinell; Ines Drenjancevic Peric; Julian H Lombard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-28       Impact factor: 3.619

3.  Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats.

Authors:  Bin Zhang; Cheng-Gang Zhang; Quan-Bo Zhou; Wei Chen; Zhi-Yong Wu
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

4.  Impaired HSP70 Expression in the Aorta of Female Rats: A Novel Insight Into Sex-Specific Differences in Vascular Function.

Authors:  Amanda Almeida de Oliveira; Fernanda Priviero; R Clinton Webb; Kenia Pedrosa Nunes
Journal:  Front Physiol       Date:  2021-04-22       Impact factor: 4.566

5.  Age-, Gender-, and in Vivo Different Doses of Isoproterenol Modify in Vitro Aortic Vasoreactivity and Circulating VCAM-1.

Authors:  Betzabé Nieto-Lima; Agustina Cano-Martínez; María E Rubio-Ruiz; Israel Pérez-Torres; Verónica Guarner-Lans
Journal:  Front Physiol       Date:  2018-01-24       Impact factor: 4.566

6.  Gender differences in vascular reactivity of mesenteric arterioles in portal hypertensive and non-portal hypertensive rats.

Authors:  Bin Zhang; Lin-Hua Ji; Cheng-Gang Zhang; Gang Zhao; Zhi-Yong Wu
Journal:  World J Gastroenterol       Date:  2019-10-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.